Key Findings:  Geraniol in the current study improved experimental colitis partly via its antioxidant, anti-inflammatory, and immunosuppressive potentials, possibly by modulating the Wnt/GSK-3β/β-catenin, p38MAPK, NFκB, and PPARγ signaling pathways.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Egypt
Year of Pub:  2015
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  Geraniol
Receptors Studied:  PPAR - Gamma